This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kolaczynski, J. W. Articles by Considine, R. V. Search for Related Content PubMed PubMed Citation Articles by Kolaczynski, J. W. Articles by Considine, R. V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE Medline Plus Health Information Obesity

Dexamethasone, OB Gene, and Leptin in Humans; Effect of Exogenous Hyperinsulinemia¹

Division of Endocrinology, Diabetes and Metabolic Diseases, Thomas Jefferson University (J.W.K., B.J.G.), Philadelphia, Pennsylvania 19107; and University of Indiana Medical Center (R.V.C.), Indianapolis, Indiana

Address all correspondence and requests for reprints to: Jerzy W. Kolaczynski, Division of Endocrinology, Diabetes and Metabolic Diseases, Thomas Jefferson University, 211 South 9th Street, Suite 600, Philadelphia, Pennsylvania 19107.

This study was undertaken to investigate temporal association between dexamethasone administration, OB gene expression, and leptin response in humans in the presence and absence of exogenous hyperinsulinemia. Six healthy males (age 24.5 ± 1.0 yr, body mass index 26.4 ± 1.0, body fat 16.2 ± 1.8%) received 10 mg oral dexamethasone in five divided doses twice (protocols A and B) 1–2 weeks apart beginning at 0800 h on day 1 and ending at 0700 h on day 2. The dexamethasone administration was combined with two subcutaneous abdominal fat biopsies performed at 0800 h before and after dexamethasone administration (protocol A), or 4-h isoglycemic hyperinsulinemic (300 mU/m² BSA/min, protocol B) clamp carried out between 0900 and 1300 h on day 2. OB gene expression (protocol A) did not change. In both protocols on day 2, the 0800 h leptin levels nearly doubled (P < 0.001), whereas 1300 h levels nearly quadrupled (P < 0.001). The elevation in leptin persisted until 0800 h of day 3 (24 h after last dexamethasone dose) with its subsequent rapid normalization. The short-term isoglycemic hyperinsulinemia (protocol B) had no additional effect on the postdexamethasone leptin response. We summarize that: 1) 24-h administration of dexamethasone has a marked stimulatory effect on circulating leptin levels but not on OB gene expression in the subcutaneous abdominal fat. 2) The effect is sustained for the next 24 h. 3) Short-term hyperinsulinemia has no additional effect. We conclude that dexamethasone is a powerful stimulator of leptin production in vivo through a mechanism that appears to be independent of OB gene transcription in the human subcutaneous abdominal fat.

This article has been cited by other articles:

				H. Muller, N. Schweitzer, O. Johren, P. Dominiak, and W. Raasch Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E802 - E810. [Abstract] [Full Text] [PDF]

				M J Moreno-Aliaga, M M Swarbrick, S Lorente-Cebrian, K L Stanhope, P J Havel, and J A Martinez Sp1-mediated transcription is involved in the induction of leptin by insulin-stimulated glucose metabolism J. Mol. Endocrinol., May 1, 2007; 38(5): 537 - 546. [Abstract] [Full Text] [PDF]

				G. E. Sonnenberg, G. R. Krakower, R. G. Hoffmann, D. L. Maas, M. M. I. Hennes, and A. H. Kissebah Plasma Leptin Concentrations during Extended Fasting and Graded Glucose Infusions: Relationships with Changes in Glucose, Insulin, and FFA J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4895 - 4900. [Abstract] [Full Text] [PDF]

				S. K. Fried, M. R. Ricci, C. D. Russell, and B. Laferrere Regulation of Leptin Production in Humans J. Nutr., December 1, 2000; 130 (12): 3127S - 3131S. [Abstract] [Full Text] [PDF]

				P C Ng, C W K Lam, C H Lee, G W K Wong, T F Fok, E Wong, K C Ma, and I H S Chan Leptin and metabolic hormones in infants of diabetic mothers Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2000; 83(3): 193F - 197. [Abstract] [Full Text]

				R. V. Considine, R. C. Cooksey, L. B. Williams, R. L. Fawcett, P. Zhang, W. T. Ambrosius, R. M. Whitfield, R. Jones, M. Inman, J. Huse, et al. Hexosamines Regulate Leptin Production in Human Subcutaneous Adipocytes J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3551 - 3556. [Abstract] [Full Text]

				L. B. Williams, R. L. Fawcett, A. S. Waechter, P. Zhang, B. E. Kogon, R. Jones, M. Inman, J. Huse, and R. V. Considine Leptin Production in Adipocytes from Morbidly Obese Subjects: Stimulation by Dexamethasone, Inhibition with Troglitazone, and Influence of Gender J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2678 - 2684. [Abstract] [Full Text]

				F. S. L. Thong, R. Hudson, R. Ross, I. Janssen, and T. E. Graham Plasma leptin in moderately obese men: independent effects of weight loss and aerobic exercise Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E307 - E313. [Abstract] [Full Text] [PDF]

				T. Hytinantti, H. A Koistinen, V. A Koivisto, S.-L. Karonen, E.-M. Rutanen, S. Andersson;, A. BEREZIN, and M. MELO Increased leptin concentration in preterm infants of pre-eclamptic mothers Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 13F - 16. [Abstract] [Full Text]

				J. Q. Purnell and M. H. Samuels Levels of Leptin during Hydrocortisone Infusions that Mimic Normal and Reversed Diurnal Cortisol Levels in Subjects with Adrenal Insufficiency J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3125 - 3128. [Abstract] [Full Text]

				L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF]

				H. H. Zhang, S. Kumar, A. H. Barnett, and M. C. Eggo Intrinsic Site-Specific Differences in the Expression of Leptin in Human Adipocytes and Its Autocrine Effects on Glucose Uptake J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2550 - 2556. [Abstract] [Full Text]

				C. D. Russell, R. N. Petersen, S. P. Rao, M. R. Ricci, A. Prasad, Y. Zhang, R. E. Brolin, and S. K. Fried Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E507 - E515. [Abstract] [Full Text] [PDF]

				D. Torpy, S. Bornstein, G Cizza, and G. Chrousos The Effects of Glucocorticoids on Leptin Levels in Humans May Be Restricted to Acute Pharmacologic Dosinga J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1821 - 1822. [Full Text]

				J. W. Kolaczynski Dexamethasone, OB Gene, and Leptin in Humans: Effect of Exogenous Hyperinsulinemia--Author's Responseb J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1822 - 1822. [Full Text]

				P. J. Havel, J. Y. Uriu-Hare, T. Liu, K. L. Stanhope, J. S. Stern, C. L. Keen, and B. Ahren Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1482 - R1491. [Abstract] [Full Text] [PDF]